Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. VRDN
5. NVDA
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
(NASDAQ: APVO) Delayed: 4.55 --0 (-0%)
Previous Close $4.55    52 Week High $4.33 
Open $4.62    52 Week Low $1.80 
Day High $4.71    P/E N/A 
Day Low $4.50    EPS $0.00 
Volume 9,424